Anspach Investments

Anspach Investments is a private investment firm based in Palm Beach Gardens, Florida, that focuses on the life sciences and biotechnology sectors. The firm was established by William E. Anspach Jr. following the successful sale of his medical device company, The Anspach Effort, to Synthes in 2010. Anspach Investments primarily engages in early-stage venture capital, providing funding and strategic support to companies developing innovative therapies for neurodegenerative diseases, oncology, and rare disorders. The firm is recognized for its participation in the financing of several high-profile biotechnology companies, including Denali Therapeutics, Alector, and Annexon Biosciences. By leveraging deep industry expertise and a long-term investment horizon, Anspach Investments plays a significant role in advancing the next generation of medical breakthroughs.